Pink SheetUS Food and Drug Administration approval of Lumicell Inc. ’s optical imaging agent Lumisight (pegulicianine) brought the number of novel imaging agents to clear the agency’s Center for Drug Evaluatio
Medtech InsightBill Preventing Lab Cuts Reintroduced In US Congress Lawmakers in both houses of the US Congress have reintroduced legislation that would reverse planned cuts to Medicare lab reimbursements, which sup
Pink SheetThe US FDA’s approval of Ferring Pharmaceuticals ’ bladder cancer gene therapy Adstiladrin just two weeks after the company took home an approval for the pioneering microbiome therapeutic Rebyota res
Pink SheetThe US Food and Drug Administration’s plan to transition certain products regulated as drugs to device status could have significant repercussions for the pharmaceutical industry. While the agency is